1-(2-methoxyethyl)-4-methylpiperidine;9-methylacridine;9-methylanthracene;1-methyl-3,5-diphenylbenzene;4-methyl-2,6-diphenylpyridine;methyl 4-(4-methyl-6-morpholin-4-yl-2-pyridinyl)benzoate;4-[4-methyl-6-(3-methylphenyl)-2-pyridinyl]morpholine;4-[4-methyl-6-(4-methylphenyl)-2-pyridinyl]morpholine;9-methylphenanthrene;4-(4-methyl-6-phenyl-2-pyridinyl)morpholine

C158H163N11O7 — CID 164983710

IUPAC1-(2-methoxyethyl)-4-methylpiperidine;9-methylacridine;9-methylanthracene;1-methyl-3,5-diphenylbenzene;4-methyl-2,6-diphenylpyridine;methyl 4-(4-methyl-6-morpholin-4-yl-2-pyridinyl)benzoate;4-[4-methyl-6-(3-methylphenyl)-2-pyridinyl]morpholine;4-[4-methyl-6-(4-methylphenyl)-2-pyridinyl]morpholine;9-methylphenanthrene;4-(4-methyl-6-phenyl-2-pyridinyl)morpholine
SMILESCOC(=O)c1ccc(-c2cc(C)cc(N3CCOCC3)n2)cc1.COCCN1CCC(C)CC1.Cc1c2ccccc2cc2ccccc12.Cc1c2ccccc2nc2ccccc12.Cc1cc(-c2ccccc2)cc(-c2ccccc2)c1.Cc1cc(-c2ccccc2)nc(-c2ccccc2)c1.Cc1cc(-c2ccccc2)nc(N2CCOCC2)c1.Cc1cc2ccccc2c2ccccc12.Cc1ccc(-c2cc(C)cc(N3CCOCC3)n2)cc1.Cc1cccc(-c2cc(C)cc(N3CCOCC3)n2)c1
InChIInChI=1S/C19H16.C18H20N2O3.C18H15N.2C17H20N2O.C16H18N2O.2C15H12.C14H11N.C9H19NO/c1-15-12-18(16-8-4-2-5-9-16)14-19(13-15)17-10-6-3-7-11-17;1-13-11-16(14-3-5-15(6-4-14)18(21)22-2)19-17(12-13)20-7-9-23-10-8-20;1-14-12-17(15-8-4-2-5-9-15)19-18(13-14)16-10-6-3-7-11-16;1-13-3-5-15(6-4-13)16-11-14(2)12-17(18-16)19-7-9-20-10-8-19;1-13-4-3-5-15(10-13)16-11-14(2)12-17(18-16)19-6-8-20-9-7-19;1-13-11-15(14-5-3-2-4-6-14)17-16(12-13)18-7-9-19-10-8-18;1-11-14-8-4-2-6-12(14)10-13-7-3-5-9-15(11)13;1-11-10-12-6-2-3-8-14(12)15-9-5-4-7-13(11)15;1-10-11-6-2-4-8-13(11)15-14-9-5-3-7-12(10)14;1-9-3-5-10(6-4-9)7-8-11-2/h2-14H,1H3;3-6,11-12H,7-10H2,1-2H3;2-13H,1H3;3-6,11-12H,7-10H2,1-2H3;3-5,10-12H,6-9H2,1-2H3;2-6,11-12H,7-10H2,1H3;2*2-10H,1H3;2-9H,1H3;9H,3-8H2,1-2H3
InChIKeyFVVMJTQXSGKPNP-UHFFFAOYSA-N
MW2328.11 g/mol
LogP35.69
Rot. Bonds16

About 1-(2-methoxyethyl)-4-methylpiperidine;9-methylacridine;9-methylanthracene;1-methyl-3,5-diphenylbenzene;4-methyl-2,6-diphenylpyridine;methyl 4-(4-methyl-6-morpholin-4-yl-2-pyridinyl)benzoate;4-[4-methyl-6-(3-methylphenyl)-2-pyridinyl]morpholine;4-[4-methyl-6-(4-methylphenyl)-2-pyridinyl]morpholine;9-methylphenanthrene;4-(4-methyl-6-phenyl-2-pyridinyl)morpholine

1-(2-methoxyethyl)-4-methylpiperidine;9-methylacridine;9-methylanthracene;1-methyl-3,5-diphenylbenzene;4-methyl-2,6-diphenylpyridine;methyl 4-(4-methyl-6-morpholin-4-yl-2-pyridinyl)benzoate;4-[4-methyl-6-(3-methylphenyl)-2-pyridinyl]morpholine;4-[4-methyl-6-(4-methylphenyl)-2-pyridinyl]morpholine;9-methylphenanthrene;4-(4-methyl-6-phenyl-2-pyridinyl)morpholine (PubChem CID 164983710) has the molecular formula C158H163N11O7 and a molecular weight of 2328.11 g/mol. Its IUPAC name is 1-(2-methoxyethyl)-4-methylpiperidine;9-methylacridine;9-methylanthracene;1-methyl-3,5-diphenylbenzene;4-methyl-2,6-diphenylpyridine;methyl 4-(4-methyl-6-morpholin-4-yl-2-pyridinyl)benzoate;4-[4-methyl-6-(3-methylphenyl)-2-pyridinyl]morpholine;4-[4-methyl-6-(4-methylphenyl)-2-pyridinyl]morpholine;9-methylphenanthrene;4-(4-methyl-6-phenyl-2-pyridinyl)morpholine.

Molecular Properties

Compound Name1-(2-methoxyethyl)-4-methylpiperidine;9-methylacridine;9-methylanthracene;1-methyl-3,5-diphenylbenzene;4-methyl-2,6-diphenylpyridine;methyl 4-(4-methyl-6-morpholin-4-yl-2-pyridinyl)benzoate;4-[4-methyl-6-(3-methylphenyl)-2-pyridinyl]morpholine;4-[4-methyl-6-(4-methylphenyl)-2-pyridinyl]morpholine;9-methylphenanthrene;4-(4-methyl-6-phenyl-2-pyridinyl)morpholine
PubChem CID164983710
Molecular FormulaC158H163N11O7
Molecular Weight2328.11 g/mol
Exact Mass2326.27
IUPAC Name1-(2-methoxyethyl)-4-methylpiperidine;9-methylacridine;9-methylanthracene;1-methyl-3,5-diphenylbenzene;4-methyl-2,6-diphenylpyridine;methyl 4-(4-methyl-6-morpholin-4-yl-2-pyridinyl)benzoate;4-[4-methyl-6-(3-methylphenyl)-2-pyridinyl]morpholine;4-[4-methyl-6-(4-methylphenyl)-2-pyridinyl]morpholine;9-methylphenanthrene;4-(4-methyl-6-phenyl-2-pyridinyl)morpholine
SMILESCOC(=O)c1ccc(-c2cc(C)cc(N3CCOCC3)n2)cc1.COCCN1CCC(C)CC1.Cc1c2ccccc2cc2ccccc12.Cc1c2ccccc2nc2ccccc12.Cc1cc(-c2ccccc2)cc(-c2ccccc2)c1.Cc1cc(-c2ccccc2)nc(-c2ccccc2)c1.Cc1cc(-c2ccccc2)nc(N2CCOCC2)c1.Cc1cc2ccccc2c2ccccc12.Cc1ccc(-c2cc(C)cc(N3CCOCC3)n2)cc1.Cc1cccc(-c2cc(C)cc(N3CCOCC3)n2)c1
InChIInChI=1S/C19H16.C18H20N2O3.C18H15N.2C17H20N2O.C16H18N2O.2C15H12.C14H11N.C9H19NO/c1-15-12-18(16-8-4-2-5-9-16)14-19(13-15)17-10-6-3-7-11-17;1-13-11-16(14-3-5-15(6-4-14)18(21)22-2)19-17(12-13)20-7-9-23-10-8-20;1-14-12-17(15-8-4-2-5-9-15)19-18(13-14)16-10-6-3-7-11-16;1-13-3-5-15(6-4-13)16-11-14(2)12-17(18-16)19-7-9-20-10-8-19;1-13-4-3-5-15(10-13)16-11-14(2)12-17(18-16)19-6-8-20-9-7-19;1-13-11-15(14-5-3-2-4-6-14)17-16(12-13)18-7-9-19-10-8-18;1-11-14-8-4-2-6-12(14)10-13-7-3-5-9-15(11)13;1-11-10-12-6-2-3-8-14(12)15-9-5-4-7-13(11)15;1-10-11-6-2-4-8-13(11)15-14-9-5-3-7-12(10)14;1-9-3-5-10(6-4-9)7-8-11-2/h2-14H,1H3;3-6,11-12H,7-10H2,1-2H3;2-13H,1H3;3-6,11-12H,7-10H2,1-2H3;3-5,10-12H,6-9H2,1-2H3;2-6,11-12H,7-10H2,1H3;2*2-10H,1H3;2-9H,1H3;9H,3-8H2,1-2H3
InChIKeyFVVMJTQXSGKPNP-UHFFFAOYSA-N
XLogP35.69
TPSA165.99 Ų
H-Bond Donors
H-Bond Acceptors18
Rotatable Bonds16
Heavy Atoms176
Complexity—

Lipinski Rule of Five

3 violations

RuleValue
MW ≤ 5002328.11
LogP ≤ 535.69
H-Bond Donors ≤ 50
H-Bond Acceptors ≤ 1018

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'Polycyclic_aromatic_hydrocarbon_2', 'substructure': 'N/A'}, {'alert_name': 'Polycyclic_aromatic_hydrocarbon_3', 'substructure': 'N/A'}

Analyze 1-(2-methoxyethyl)-4-methylpiperidine;9-methylacridine;9-methylanthracene;1-methyl-3,5-diphenylbenzene;4-methyl-2,6-diphenylpyridine;methyl 4-(4-methyl-6-morpholin-4-yl-2-pyridinyl)benzoate;4-[4-methyl-6-(3-methylphenyl)-2-pyridinyl]morpholine;4-[4-methyl-6-(4-methylphenyl)-2-pyridinyl]morpholine;9-methylphenanthrene;4-(4-methyl-6-phenyl-2-pyridinyl)morpholine with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

methyl 4-(4-methyl-6-morpholin-4-yl-2-pyridinyl)benzoate;4-methyl-2-(3-methylphenyl)pyridine;4-[4-methyl-6-(3-methylphenyl)-2-pyridinyl]morpholine;4-[4-methyl-6-(4-methylphenyl)-2-pyridinyl]morpholine;methyl 4-(4-methyl-2-pyridinyl)benzoate;4-methyl-2-phenylpyridine;4-(4-methyl-6-phenyl-2-pyridinyl)morpholine
CID 158873466
2-(3-methylphenyl)-N-(2-morpholin-4-ylethyl)quinoline-4-carboxamide
CID 4110000
methyl 4-(6-morpholin-4-yl-2-phenylpyrimidin-4-yl)oxybenzoate
CID 23827389
[2-(4-morpholin-4-ylanilino)-2-oxoethyl] 2-phenylquinoline-4-carboxylate
CID 2358673
[2-(3-methylphenyl)-4-oxoquinazolin-3-yl] 4-methylbenzoate
CID 118737735
methyl 3-morpholin-4-yl-2-phenylquinoxaline-6-carboxylate
CID 67042135
N-(4-methylphenyl)-2-morpholin-4-ylquinoline-4-carboxamide
CID 659672
4-[2-(2-methoxyethyl)-6-[3-(3-methylphenyl)pyrazol-1-yl]pyrimidin-4-yl]morpholine
CID 156831967
dimethyl 5-[[2-(3-methylphenyl)quinoline-4-carbonyl]amino]benzene-1,3-dicarboxylate
CID 1224618
(2-morpholin-4-yl-2-oxoethyl) 2-(4-phenylphenyl)quinoline-4-carboxylate
CID 3501639
2-(4-ethylphenyl)-N-(2-morpholin-4-ylethyl)quinoline-4-carboxamide
CID 4184624
4-[6-(3-methylphenyl)-2-(2-piperidin-1-ylethoxy)quinazolin-4-yl]morpholine
CID 143533307

Frequently Asked Questions

What is the IUPAC name of 1-(2-methoxyethyl)-4-methylpiperidine;9-methylacridine;9-methylanthracene;1-methyl-3,5-diphenylbenzene;4-methyl-2,6-diphenylpyridine;methyl 4-(4-methyl-6-morpholin-4-yl-2-pyridinyl)benzoate;4-[4-methyl-6-(3-methylphenyl)-2-pyridinyl]morpholine;4-[4-methyl-6-(4-methylphenyl)-2-pyridinyl]morpholine;9-methylphenanthrene;4-(4-methyl-6-phenyl-2-pyridinyl)morpholine?
The IUPAC name of 1-(2-methoxyethyl)-4-methylpiperidine;9-methylacridine;9-methylanthracene;1-methyl-3,5-diphenylbenzene;4-methyl-2,6-diphenylpyridine;methyl 4-(4-methyl-6-morpholin-4-yl-2-pyridinyl)benzoate;4-[4-methyl-6-(3-methylphenyl)-2-pyridinyl]morpholine;4-[4-methyl-6-(4-methylphenyl)-2-pyridinyl]morpholine;9-methylphenanthrene;4-(4-methyl-6-phenyl-2-pyridinyl)morpholine (CID 164983710) is 1-(2-methoxyethyl)-4-methylpiperidine;9-methylacridine;9-methylanthracene;1-methyl-3,5-diphenylbenzene;4-methyl-2,6-diphenylpyridine;methyl 4-(4-methyl-6-morpholin-4-yl-2-pyridinyl)benzoate;4-[4-methyl-6-(3-methylphenyl)-2-pyridinyl]morpholine;4-[4-methyl-6-(4-methylphenyl)-2-pyridinyl]morpholine;9-methylphenanthrene;4-(4-methyl-6-phenyl-2-pyridinyl)morpholine.
What is the SMILES notation for 1-(2-methoxyethyl)-4-methylpiperidine;9-methylacridine;9-methylanthracene;1-methyl-3,5-diphenylbenzene;4-methyl-2,6-diphenylpyridine;methyl 4-(4-methyl-6-morpholin-4-yl-2-pyridinyl)benzoate;4-[4-methyl-6-(3-methylphenyl)-2-pyridinyl]morpholine;4-[4-methyl-6-(4-methylphenyl)-2-pyridinyl]morpholine;9-methylphenanthrene;4-(4-methyl-6-phenyl-2-pyridinyl)morpholine?
The canonical SMILES for 1-(2-methoxyethyl)-4-methylpiperidine;9-methylacridine;9-methylanthracene;1-methyl-3,5-diphenylbenzene;4-methyl-2,6-diphenylpyridine;methyl 4-(4-methyl-6-morpholin-4-yl-2-pyridinyl)benzoate;4-[4-methyl-6-(3-methylphenyl)-2-pyridinyl]morpholine;4-[4-methyl-6-(4-methylphenyl)-2-pyridinyl]morpholine;9-methylphenanthrene;4-(4-methyl-6-phenyl-2-pyridinyl)morpholine is COC(=O)c1ccc(-c2cc(C)cc(N3CCOCC3)n2)cc1.COCCN1CCC(C)CC1.Cc1c2ccccc2cc2ccccc12.Cc1c2ccccc2nc2ccccc12.Cc1cc(-c2ccccc2)cc(-c2ccccc2)c1.Cc1cc(-c2ccccc2)nc(-c2ccccc2)c1.Cc1cc(-c2ccccc2)nc(N2CCOCC2)c1.Cc1cc2ccccc2c2ccccc12.Cc1ccc(-c2cc(C)cc(N3CCOCC3)n2)cc1.Cc1cccc(-c2cc(C)cc(N3CCOCC3)n2)c1.
What is the InChIKey of 1-(2-methoxyethyl)-4-methylpiperidine;9-methylacridine;9-methylanthracene;1-methyl-3,5-diphenylbenzene;4-methyl-2,6-diphenylpyridine;methyl 4-(4-methyl-6-morpholin-4-yl-2-pyridinyl)benzoate;4-[4-methyl-6-(3-methylphenyl)-2-pyridinyl]morpholine;4-[4-methyl-6-(4-methylphenyl)-2-pyridinyl]morpholine;9-methylphenanthrene;4-(4-methyl-6-phenyl-2-pyridinyl)morpholine?
The InChIKey is FVVMJTQXSGKPNP-UHFFFAOYSA-N. The full InChI is InChI=1S/C19H16.C18H20N2O3.C18H15N.2C17H20N2O.C16H18N2O.2C15H12.C14H11N.C9H19NO/c1-15-12-18(16-8-4-2-5-9-16)14-19(13-15)17-10-6-3-7-11-17;1-13-11-16(14-3-5-15(6-4-14)18(21)22-2)19-17(12-13)20-7-9-23-10-8-20;1-14-12-17(15-8-4-2-5-9-15)19-18(13-14)16-10-6-3-7-11-16;1-13-3-5-15(6-4-13)16-11-14(2)12-17(18-16)19-7-9-20-10-8-19;1-13-4-3-5-15(10-13)16-11-14(2)12-17(18-16)19-6-8-20-9-7-19;1-13-11-15(14-5-3-2-4-6-14)17-16(12-13)18-7-9-19-10-8-18;1-11-14-8-4-2-6-12(14)10-13-7-3-5-9-15(11)13;1-11-10-12-6-2-3-8-14(12)15-9-5-4-7-13(11)15;1-10-11-6-2-4-8-13(11)15-14-9-5-3-7-12(10)14;1-9-3-5-10(6-4-9)7-8-11-2/h2-14H,1H3;3-6,11-12H,7-10H2,1-2H3;2-13H,1H3;3-6,11-12H,7-10H2,1-2H3;3-5,10-12H,6-9H2,1-2H3;2-6,11-12H,7-10H2,1H3;2*2-10H,1H3;2-9H,1H3;9H,3-8H2,1-2H3.
What are the key properties of 1-(2-methoxyethyl)-4-methylpiperidine;9-methylacridine;9-methylanthracene;1-methyl-3,5-diphenylbenzene;4-methyl-2,6-diphenylpyridine;methyl 4-(4-methyl-6-morpholin-4-yl-2-pyridinyl)benzoate;4-[4-methyl-6-(3-methylphenyl)-2-pyridinyl]morpholine;4-[4-methyl-6-(4-methylphenyl)-2-pyridinyl]morpholine;9-methylphenanthrene;4-(4-methyl-6-phenyl-2-pyridinyl)morpholine?
1-(2-methoxyethyl)-4-methylpiperidine;9-methylacridine;9-methylanthracene;1-methyl-3,5-diphenylbenzene;4-methyl-2,6-diphenylpyridine;methyl 4-(4-methyl-6-morpholin-4-yl-2-pyridinyl)benzoate;4-[4-methyl-6-(3-methylphenyl)-2-pyridinyl]morpholine;4-[4-methyl-6-(4-methylphenyl)-2-pyridinyl]morpholine;9-methylphenanthrene;4-(4-methyl-6-phenyl-2-pyridinyl)morpholine has a molecular weight of 2328.11 g/mol, XLogP of 35.69, 16 rotatable bonds, 0 hydrogen bond donors, and 18 hydrogen bond acceptors.
Where does this data come from?
All data for 1-(2-methoxyethyl)-4-methylpiperidine;9-methylacridine;9-methylanthracene;1-methyl-3,5-diphenylbenzene;4-methyl-2,6-diphenylpyridine;methyl 4-(4-methyl-6-morpholin-4-yl-2-pyridinyl)benzoate;4-[4-methyl-6-(3-methylphenyl)-2-pyridinyl]morpholine;4-[4-methyl-6-(4-methylphenyl)-2-pyridinyl]morpholine;9-methylphenanthrene;4-(4-methyl-6-phenyl-2-pyridinyl)morpholine is sourced from PubChem (CID 164983710), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).